Kosakai N, Igari J, Kumamoto Y, Sakai S, Shigeta S, Shiraiwa Y, Abe K, Tazaki H, Iri H, Uchida H
Jpn J Antibiot. 1985 Aug;38(8):2243-312.
The in vitro antimicrobial activities of antibiotics against causative pathogens isolated from patients with urinary tract infections (UTI) in the 8 institutions in Japan during the period from 1980 to 1983 were compared. A number of new beta-lactam antibiotics with broad spectrum of activity have become available for clinical use in recent years. Some of them, in particular so-called third generation cephems, are reported to be responsible for developing microbial-cross resistance to multiple beta-lactam antibiotics. We have been making survey in recent years to explore changes in susceptibility to various antimicrobial agents of clinical isolates. All bacterial isolates from clinical specimens were submitted to the Department of Clinical Pathology, Juntendo University School of Medicine, where they were tested for antimicrobial susceptibility with MIC 2000 apparatus. Of all pathogens from patients with simple UTI, the majority of the isolates was E. coli and Klebsiella spp. In cases of complicated UTI, on the other hand, Pseudomonas spp. were most frequent, followed in order by Proteus spp., Klebsiella spp., Serratia spp., Citrobacter spp. and E. coli. Conspicuous changes in antimicrobial activity of antibiotics against E. coli and Klebsiella spp. from simple UTI have not been found in our survey. Against strains of Citrobacter spp., even the third generation cephems proved to be not remarkably active and there was a significant decrease in susceptibility of isolates to the drugs test-showed MIC values of 50 micrograms/ml and the proportion increased to 50% (22/44) with isolates obtained in 1982. The antimicrobial activity of cefsulodin and gentamicin against P. aeruginosa was decreased in 1982 compared with that in 1980 and 1981. However, resistant strains were slightly more frequent with gentamicin. In 1983, the antimicrobial activity of third generation cephems against Serratia spp. was significantly reduced from that in 1982.
对1980年至1983年期间日本8家机构从尿路感染(UTI)患者中分离出的致病病原体进行了抗生素体外抗菌活性比较。近年来,许多具有广谱活性的新型β-内酰胺抗生素已可用于临床。其中一些,特别是所谓的第三代头孢菌素,据报道会导致微生物对多种β-内酰胺抗生素产生交叉耐药性。近年来我们一直在进行调查,以探索临床分离株对各种抗菌药物敏感性的变化。所有临床标本中的细菌分离株都被送到顺天堂大学医学院临床病理科,在那里用MIC 2000仪器检测它们的抗菌敏感性。在单纯性UTI患者的所有病原体中,大多数分离株是大肠杆菌和克雷伯菌属。另一方面,在复杂性UTI病例中,铜绿假单胞菌最为常见,其次依次是变形杆菌属、克雷伯菌属、沙雷菌属、柠檬酸杆菌属和大肠杆菌。在我们的调查中,未发现抗生素对单纯性UTI的大肠杆菌和克雷伯菌属的抗菌活性有明显变化。对于柠檬酸杆菌属菌株,即使是第三代头孢菌素也没有显示出显著活性,并且分离株对这些药物的敏感性显著下降——测试显示MIC值为50微克/毫升,1982年获得的分离株中这一比例增加到了50%(22/44)。与1980年和1981年相比,1982年头孢磺啶和庆大霉素对铜绿假单胞菌的抗菌活性有所下降。然而,庆大霉素的耐药菌株略多一些。1983年,第三代头孢菌素对沙雷菌属的抗菌活性比1982年显著降低。